Have the explicitly said "Mesoblast will now focus on its original strategy to first gain pediatric approval for RYONCIL, followed by label extension in the larger adult" before? Rather confident.
Have the explicitly said "Mesoblast will now focus on its...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.04 |
Change
0.010(0.98%) |
Mkt cap ! $1.198B | |||
| Open | High | Low | Value | Volume |
| $1.02 | $1.07 | $1.02 | $3.165M | 3.043M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 163763 | $1.04 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.04 | 39556 | 12 |
View Market Depth
| Last trade - 11.32am 07/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.05 |
Change
0.010 ( 1.89 %) |
||||
| Open | High | Low | Volume | ||
| $1.02 | $1.07 | $1.02 | 479223 | ||
| Last updated 11.50am 07/06/2024 ? | |||||
| MSB (ASX) Chart |